CS
GCVRZ

Credit Suisse’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Credit Suisse’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,888
Closed -$9K – 4137
2018
Q3 		$9K Hold
16,888
– – ﹤0.01% 3758
2018
Q2 		$9K Hold
16,888
– – ﹤0.01% 3941
2018
Q1 		$8K Hold
16,888
– – ﹤0.01% 3942
2017
Q4 		$6K Hold
16,888
– – ﹤0.01% 3956
2017
Q3 		$6K Hold
16,888
– – ﹤0.01% 4162
2017
Q2 		$6K Hold
16,888
– – ﹤0.01% 3812
2017
Q1 		$8K Hold
16,888
– – ﹤0.01% 3779
2016
Q4 		$6K Hold
16,888
– – ﹤0.01% 4072
2016
Q3 		$4K Hold
16,888
– – ﹤0.01% 4063
2016
Q2 		$4K Hold
16,888
– – ﹤0.01% 4180
2016
Q1 		$2K Sell
16,888
-880
-5% -$95 ﹤0.01% 3948
2015
Q4 		$2K Hold
17,768
– – ﹤0.01% 4194
2015
Q3 		$3K Buy
+17,768
New +$6.04K ﹤0.01% 4233

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Credit Suisse's GCVRZ Position: Q4 2018 in Review

Credit Suisse sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2018, closing a stake of 16,888 shares — an estimated $9K sold.

Credit Suisse first reported a position in GCVRZ in Q3 2015 and held it in 13 quarters. The position peaked at $9K in Q3 2018. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.

  • Credit Suisse reported no remaining Sanofi Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
  • Credit Suisse sold 16,888 Sanofi Contingent Value Rights shares in Q4 2018, an estimated $9K.
  • Credit Suisse first reported a position in Sanofi Contingent Value Rights in Q3 2015 and held it in 13 quarters.
  • Credit Suisse's Sanofi Contingent Value Rights position peaked at $9K in Q3 2018.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.

Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.